Ménard J - Search Results

1

Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.

Azizi M, Bissery A, Lamarre-Cliche M, Ménard J. Azizi M, et al. Among authors: menard j. Hypertension. 2004 Apr;43(4):785-90. doi: 10.1161/01.HYP.0000125698.00128.64. Epub 2004 Mar 15. Hypertension. 2004. PMID: 15023936 Clinical Trial.

2

Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake.

Azizi M, Lamarre-Cliche M, Labatide-Alanore A, Bissery A, Guyene TT, Ménard J. Azizi M, et al. Among authors: menard j. J Am Soc Nephrol. 2002 Oct;13(10):2454-63. doi: 10.1097/01.asn.0000030142.80452.11. J Am Soc Nephrol. 2002. PMID: 12239234 Clinical Trial.

3

Dual renin-angiotensin system blockade restores blood pressure-renin dependency in individuals with low renin concentrations.

Azizi M, Bissery A, Bura-Rivière A, Ménard J. Azizi M, et al. Among authors: menard j. J Hypertens. 2003 Oct;21(10):1887-95. doi: 10.1097/00004872-200310000-00016. J Hypertens. 2003. PMID: 14508195 Clinical Trial.

4

Renin-angiotensin system blockade: to what extent?

Ménard J, Azizi M. Ménard J, et al. J Hypertens. 2004 Mar;22(3):459-62. doi: 10.1097/00004872-200403000-00005. J Hypertens. 2004. PMID: 15076148 Review. No abstract available.

5

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.

Azizi M, Ménard J. Azizi M, et al. Among authors: menard j. Circulation. 2004 Jun 1;109(21):2492-9. doi: 10.1161/01.CIR.0000131449.94713.AD. Circulation. 2004. PMID: 15173039 Review. No abstract available.

6

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.

Azizi M, Ménard J, Bissery A, Guyenne TT, Bura-Rivière A, Vaidyanathan S, Camisasca RP. Azizi M, et al. Among authors: menard j. J Am Soc Nephrol. 2004 Dec;15(12):3126-33. doi: 10.1097/01.ASN.0000146686.35541.29. J Am Soc Nephrol. 2004. PMID: 15579516 Clinical Trial.

7

Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.

Azizi M, Bissery A, Peyrard S, Guyene TT, Ozoux ML, Floch A, Ménard J. Azizi M, et al. Among authors: menard j. Clin Pharmacol Ther. 2006 Jan;79(1):49-61. doi: 10.1016/j.clpt.2005.09.011. Clin Pharmacol Ther. 2006. PMID: 16413241 Clinical Trial.

8

Conformational changes in prorenin during renin inhibition in vitro and in vivo.

Ménard J, Guyene TT, Peyrard S, Azizi M. Ménard J, et al. J Hypertens. 2006 Mar;24(3):529-34. doi: 10.1097/01.hjh.0000209989.59230.2e. J Hypertens. 2006. PMID: 16467656 Clinical Trial.

9

Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals.

Azizi M, Ménard J, Bissery A, Guyene TT, Bura-Rivière A. Azizi M, et al. Among authors: menard j. Clin J Am Soc Nephrol. 2007 Sep;2(5):947-55. doi: 10.2215/CJN.00360107. Epub 2007 Aug 8. Clin J Am Soc Nephrol. 2007. PMID: 17702736 Clinical Trial.

10

Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.

Bobrie G, Frank M, Azizi M, Peyrard S, Boutouyrie P, Chatellier G, Laurent S, Menard J, Plouin PF. Bobrie G, et al. Among authors: menard j. J Hypertens. 2012 Aug;30(8):1656-64. doi: 10.1097/HJH.0b013e3283551e98. J Hypertens. 2012. PMID: 22728905 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,164 results

Search Page

Filters